Impact of 68Ga-PSMA-11 PET/CT on staging and management of prostate cancer patients in various clinical settings. This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers Symposium. This ...
Overcoming acquired osimertinib-resistance in EGFR-mutant advanced non-small lung cancer mediated by activating BRAF V600E mutation. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting ...
Department of Health and Aging Australia. The Review of the AR-DRG Classification System Development Process: Brisbane, QLD, Australia: PricewaterhouseCoopers; 2009. 2. Klein-Hitpass U, ...